These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2898915)

  • 1. Antineoplastic activity of two taxol derivatives on an ovarian tumor xenografted into nude mice.
    Riondel J; Jacrot M; Nissou MF; Picot F; Bériel H; Mouriquand C; Potier P
    Anticancer Res; 1988; 8(3):387-90. PubMed ID: 2898915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of free and liposome-encapsulated taxol on two brain tumors xenografted into nude mice.
    Riondel J; Jacrot M; Fessi H; Puisieux F; Potier
    In Vivo; 1992; 6(1):23-7. PubMed ID: 1352706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Action of taxol on human tumors transplanted in athymic mice].
    Jacrot M; Riondel J; Picot F; Leroux D; Mouriquand C; Beriel H; Potier P
    C R Seances Acad Sci III; 1983; 297(13):597-600. PubMed ID: 6143600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior therapeutic profile of poly-L-glutamic acid-paclitaxel copolymer compared with taxol in xenogeneic compartmental models of human ovarian carcinoma.
    Auzenne E; Donato NJ; Li C; Leroux E; Price RE; Farquhar D; Klostergaard J
    Clin Cancer Res; 2002 Feb; 8(2):573-81. PubMed ID: 11839679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of the new vinca-alkaloid S 12363 alone or in combination with verapamil on a human multidrug resistant renal carcinoma xenograft.
    Berlion M; Arvelo F; Leonce S; Bourgeois Y; Rigaudy P; Bizzari JP; Poupon MF
    In Vivo; 1993; 7(5):399-405. PubMed ID: 7906553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with paclitaxel alone rather than combination with paclitaxel and cisplatin may be selective for cisplatin-resistant ovarian carcinoma.
    Yamamoto K; Kikuchi Y; Kudoh K; Hirata J; Kita T; Nagata I
    Jpn J Clin Oncol; 2000 Oct; 30(10):446-9. PubMed ID: 11185891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibition of a human ovarian tumor by a novel paclitaxel derivative in SCID mice.
    Ahmad I; Masters GR; Schupsky JJ; Nguyen J; Ali S; Janoff AS; Mayhew E
    Oncol Res; 1999; 11(6):273-80. PubMed ID: 10691029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors.
    Li C; Price JE; Milas L; Hunter NR; Ke S; Yu DF; Charnsangavej C; Wallace S
    Clin Cancer Res; 1999 Apr; 5(4):891-7. PubMed ID: 10213226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taxol-based combination chemotherapy and other in vivo preclinical antitumor studies.
    Rose WC
    J Natl Cancer Inst Monogr; 1993; (15):47-53. PubMed ID: 7912529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taxol as second-line treatment in patients with advanced ovarian cancer after platinum-based first-line chemotherapy.
    Mayerhofer K; Kucera E; Zeisler H; Speiser P; Reinthaller A; Sevelda P
    Gynecol Oncol; 1997 Jan; 64(1):109-13. PubMed ID: 8995557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts.
    Klement G; Huang P; Mayer B; Green SK; Man S; Bohlen P; Hicklin D; Kerbel RS
    Clin Cancer Res; 2002 Jan; 8(1):221-32. PubMed ID: 11801563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor efficacy of solid dispersion of paclitaxel prepared by supercritical antisolvent process in human mammary tumor xenografts.
    Shanmugam S; Park JH; Chi SC; Yong CS; Choi HG; Woo JS
    Int J Pharm; 2011 Jan; 403(1-2):130-5. PubMed ID: 20974239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of hydrophilic Paclitaxel copolymer prodrug using locoregional delivery in human orthotopic non-small cell lung cancer xenograft models.
    Zou Y; Fu H; Ghosh S; Farquhar D; Klostergaard J
    Clin Cancer Res; 2004 Nov; 10(21):7382-91. PubMed ID: 15534115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of the establishing individual protocol for effective chemotherapy of ovarian cancer--fundamental research using human tumor-nude mouse system].
    Sawada M; Ozaki M; Hongo J; Hirota Y; Inagaki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Oct; 39(10):1776-83. PubMed ID: 3429976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a human ovarian carcinoma cell line: UCI 101.
    Fuchtner C; Emma DA; Manetta A; Gamboa G; Bernstein R; Liao SY
    Gynecol Oncol; 1993 Feb; 48(2):203-9. PubMed ID: 8428692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts.
    Giavazzi R; Garofalo A; Ferri C; Lucchini V; Bone EA; Chiari S; Brown PD; Nicoletti MI; Taraboletti G
    Clin Cancer Res; 1998 Apr; 4(4):985-92. PubMed ID: 9563894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.
    Manetta A; Gamboa G; Nasseri A; Podnos YD; Emma D; Dorion G; Rawlings L; Carpenter PM; Bustamante A; Patel J; Rideout D
    Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy.
    Clarke K; Lee FT; Brechbiel MW; Smyth FE; Old LJ; Scott AM
    Clin Cancer Res; 2000 Sep; 6(9):3621-8. PubMed ID: 10999754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a surrogate marker (human secreted alkaline phosphatase) to monitor in vivo tumor growth and anticancer drug efficacy in ovarian cancer xenografts.
    Bao R; Selvakumaran M; Hamilton TC
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):373-9. PubMed ID: 10985897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Taxol and ovarian adenocarcinomas].
    Marty M; Extra JM; Culine S; Rousseau F
    Pathol Biol (Paris); 1992 Nov; 39(9):834-5. PubMed ID: 1347165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.